rare presentations of cytomegalovirus infection in renal allograft recipients

Rare Presentations of Cytomegalovirus Infection in Renal Allograft Recipients

Cytomegalovirus is the most common viral infection after kidney transplantation. Clinical presentations of cytomegalovirus infection range from asymptomatic infection to organ-specific involvement. Most symptomatic infections manifest as fever and cytopenia. The gastrointestinal tract is the most common site of tissue-invasive infection, often presenting as diarrhea or gastrointestinal bleeding...

Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients.

CYTOMEGALOVIRUS (CMV) is a major infectious complication of renal transplantation associated with significant morbidity and mortality. 1-3 Ganciclovir inhibits herpesvirus DNA polymerase4 and has shown antiviraJ effects in vivo in several reported clinical studies. 5-8 We report our experience with the use of ganciclovir in treating tissue-invasive CMV infection following cadaver renal transpla...

BK Virus Infection in Renal Allograft Recipients

BK virus infection is a challenging complication in renal allograft recipients and has been associated with hematuria, ureteral stenosis, nephropathy and malignancy. BK virus infection occurs early during childhood and the virus lays dormant in uroepithelial cells. Reactivation of the virus in renal transplant recipients is particularly worrisome because of its propensity to cause local damage ...

BK virus infection in renal allograft recipients.

Holoendemic cytomegalovirus infection in renal transplant recipients.

A prospective study of epidemiology and pathogenesis of cytomegalovirus (CMV) infections in transplant recipients, previously reported for 30 patients (Clin. Res. XXII, 441A, 1974), has been extended to include 35 patients who have been studied clinically and virologically for 5 to 19 months after renal transplantation (RT) (except three patients who died within three months after RT). Active C...

Cytomegalovirus infection in renal transplant recipients.

We have retrospectively analyzed the incidence of cytomegalovirus (CMV) infection in 250 consecutive renal allograft transplants performed in 244 recipients. The mean follow-up was 35.1+/-25.4 months. Immunosuppression was cyclosporine- or tacrolimus-based triple therapy. CMV infection prophylaxis with ganciclovir for 3 months post transplant was prescribed in CMV-seronegative recipients of all...